CBD Life Sciences, Inc. focuses on identifying, evaluating and acquiring undervalued opportunities with the objective of increasing shareholder value. The company is headquartered in Scottsdale, Arizona. The company went IPO on 2013-08-12. Its discovery and reporting process designed for the health care industry. The firm is focused on hospitals, nursing homes and doctor’s offices. The firm assists in protecting these organizations in protecting from cyber threats, such as the theft of patient medical records and manipulation of medical devices.
根據最新的財務報表(Form-10K),Horizon Space Acquisition II Corp 的總資產為 $70,淨損失為 $0
CBDL 的關鍵財務比率是什麼?
Horizon Space Acquisition II Corp 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
Cbd Life Sciences Inc 的收入按細分市場或地理位置如何劃分?
Horizon Space Acquisition II Corp 最大收入來源為 Investment and Related Activities,在最近的收益報告中收入為 1,326,888,000。就地區而言,United States 是 Horizon Space Acquisition II Corp 的主要市場,收入為 1,326,888,000。
Cbd Life Sciences Inc 是否盈利?
無,根據最新的財務報表,Horizon Space Acquisition II Corp 的淨損失為 $0